What type of contrast is given during Magnetic Resonance Cholangiopancreatography (MRCP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hepatobiliary contrast agents, such as gadoxetate disodium, are typically used during Magnetic Resonance Cholangiopancreatography (MRCP) to provide functional assessment of the biliary tree and detect bile leaks with high accuracy 1.

Key Points

  • MRCP with hepatobiliary contrast agents allows for the detection and localization of bile leaks with an accuracy close to 100% 1.
  • The use of contrast-enhanced MRCP (CE-MRCP) improves the accuracy of bile anatomy depiction and bile leak detection 1.
  • Hepatobiliary contrast agents, such as gadoxetate disodium, are excreted via the bile and can be used to visualize the biliary tree and detect bile leaks 1.
  • MRCP with hepatobiliary contrast agents is a non-invasive technique that does not use ionizing radiation and provides excellent anatomical information regarding the biliary tree anatomy proximal and distal to the level of injury 1.

Benefits of Hepatobiliary Contrast Agents

  • Improved accuracy in detecting bile leaks and bile duct injuries
  • Non-invasive technique that does not use ionizing radiation
  • Excellent anatomical information regarding the biliary tree anatomy
  • Can be used to guide directed approaches, such as ERCP, with brushing, percutaneous transhepatic biliary stenting, or reconstructive surgery 1

From the Research

Type of Contrast Used in MRCP

  • No contrast material is required for a standard MRCP, as it relies on heavily T2-weighted sequences to highlight static fluids in the biliary and pancreatic ducts 2, 3.
  • However, some studies have explored the use of negative oral contrast media to improve visualization of the ducts by reducing signal intensity from the gastrointestinal tract 4.
  • Hepatobiliary-specific contrast agents, such as gadolinium ethoxybenzylic diethylenetriamine pentaacetic acid (Gd-EOB-DTPA), can be used in contrast-enhanced MRCP to provide higher definition of the biliary tree and improve diagnosis of biliary complications 5.
  • The use of contrast agents can be beneficial in certain cases, but it is not a standard requirement for MRCP 2, 3, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Magnetic resonance cholangiography: past, present and future: a review.

European review for medical and pharmacological sciences, 2010

Research

[Value of negative oral contrast media in MR cholangiopancreatography (MRCP)].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.